EGFRL858R-T790M-C797S NTCC® EGFR基因三突变细胞株 BioVector NTCC质粒载体菌株细胞蛋白抗体基因保藏中心
- 价 格:¥998950
- 货 号:NTCC® EGFRL858R-T790M-C797S
- 产 地:北京
- BioVector NTCC典型培养物保藏中心
- 联系人:Dr.Xu, Biovector NTCC Inc.
电话:400-800-2947 工作QQ:1843439339 (微信同号)
邮件:Biovector@163.com
手机:18901268599
地址:北京
- 已注册
EGFRL858R-T790M-C797S NTCC® EGFR基因三突变细胞株
BioVector NTCC质粒载体菌株细胞蛋白抗体基因保藏中心
NTCC® EGFRL858R-T790M-C797S cell line refers to a type of cancer cell line that carries specific mutations in the Epidermal Growth Factor Receptor (EGFR) gene.
EGFR: This gene encodes a protein that plays a crucial role in cell growth and survival. Mutations in EGFR can lead to uncontrolled cell growth and the development of cancer.
L858R, T790M, C797S: These are specific mutations within the EGFR gene:
L858R: An activating mutation that causes the EGFR protein to become constitutively active, promoting uncontrolled cell growth.
T790M: A resistance mutation that arises in response to treatment with first-generation EGFR tyrosine kinase inhibitors (TKIs).
C797S: A further resistance mutation that emerges in response to third-generation EGFR TKIs, which were developed to overcome the T790M resistance.
Significance of EGFRL858R-T790M-C797S cell lines:
Understanding Drug Resistance: These cell lines provide valuable models for studying the mechanisms of drug resistance in lung cancer, particularly the emergence of resistance to EGFR TKIs.
Drug Discovery: They can be used to screen and develop new drugs that can overcome these resistance mechanisms and effectively target cancers with these specific EGFR mutations.
Preclinical Research: These cell lines can be used in preclinical studies to evaluate the efficacy and safety of new treatment approaches, such as targeted therapies or immunotherapies.
Key Points:
EGFRL858R-T790M-C797S cell lines represent a significant challenge in the treatment of lung cancer.
Understanding the mechanisms of resistance driven by these mutations is crucial for developing more effective therapies.
Continued research using these cell lines is essential for improving the outcomes for patients with EGFR-mutant lung cancer.
Image
生产厂家Supplier:
BioVector NTCC质粒载体菌株细胞蛋白抗体基因保藏中心
E-mail:BioVector@163.com
- 公告/新闻